SCHEMBL7871307

SCHEMBL7871307

CO[C@@H]1O[C@H](CO)[C@H](O[C@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 3/20 0.58
▸ LGALS3 P17931 2/20 0.58
▸ LGALS4 P56470 1/20 0.58
▸ MEN1 O00255 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ LGALS9 O00182 1/20 0.52
▸ LGALS1 P09382 1/20 0.52
▸ LGALS7; LGALS7B P47929 1/20 0.52
▸ AMY1A P0DUB6 1/20 0.51
▸ AMY2A P04746 1/20 0.51
▸ TYR P14679 6/20 0.48
▸ FGF1 P05230 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15215700 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL7743926 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL13125623 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL15216253 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL7146285 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL20658640 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL23475838 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL18821917 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL12070983 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL14421628 1.00 LGALS8 (0.58) LGALS8LGALS3LGALS4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310043-B1 USING COMPOUNDS WHICH BIND TO TOXINS ASSOCIATED WITH ENTERIC BACTERIAL INFECTION INCLUDING PENTAMERIC TOXINS, FOR EXAMPLE SLTS, SUCH AS THOSE FROM SALMONELLA, CAMYLOBACTER, E-COLI GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2001-10-30 — — US disclosed
EP-1056476-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF BACTERIAL DYSENTERY USING ANTIBIOTICS AND TOXIN BINDING OLIGOSACCHARIDE COMPOSITIONS SYNSORB Biotech Inc. (CA) 2000-12-06 — — EP disclosed
US-5962423-A Treatment of bacterial dysentery THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1999-10-05 — — US disclosed
WO-1999042136-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF BACTERIAL DYSENTERY USING ANTIBIOTICS AND TOXIN BINDING OLIGOSACCHARIDE COMPOSITIONS SYNSORB BIOTECH, INC. (CA) 1999-08-26 — — WO disclosed
US-5661131-A ADMINISTERING A VIBRIO TOXIN-BINDING OLIGOSACCHARIDE BOUND TO AN ABSORBENT SOLID SUPPORT BY A NONPEPTIDYL SPACER ARM; ELIMINATION FROM THE GASTROINTESTINAL TRACT SYNSORB BIOTECH, INC. (CA) 1997-08-26 — — US disclosed
US-5635606-A CONTACTING SAMPLE WITH AN OLIGOSACCHARIDE SEQUENCE COVALENTLY ATTACHED TO BIOGENIC INERT, SOLID SILICATE SUPPORT THROUGH A LINKER ARM, SEPARATING SUPPORT CONTAING TOXIN A FROM SAMPLE; TREATS ANTIBIOTIC RELATED DIARRHEA SYNSORB, BIOTECH INC. (CA) 1997-06-03 — — US disclosed
US-5627163-A ADMINISTERING OLIGOSACCHARIDE BONDED TO SUPPORT THROUGH LINKER ARM TO BIND ENTEROTOXIGENIC ESCHERICHIA SYNSORB BIOTECH, INC. (CA) 1997-05-06 — — US disclosed
US-5474986-A Galabiose derivatives modified at 3* and anomeric positions SYMBICOM AKTIEBOLAG (SE) 1995-12-12 — — US disclosed
EP-0428605-B1 SYNTHETIC RECEPTOR ANALOGUES SYMBICOM AB (SE) 1994-10-19 — — EP disclosed
EP-0428605-A1 SYNTHETIC RECEPTOR ANALOGUES. SYMBICOM AB (SE) 1991-05-29 — — EP disclosed
WO-1990001488-A1 SYNTHETIC RECEPTOR ANALOGUES SYMBICOM AKTIEBOLAG (SE) 1990-02-22 — — WO disclosed
US-4762824-A OLIGOSACCHARIDES SVENSKA SOCKERFABRIKS AB (SE) 1988-08-09 — — US disclosed
US-4657849-A Compositions and methods useful for uropathogenic bacterial identification or diagnosis and inhibition of adherence of uropathogenic bacteria to cells having a structural element similar to that of the active principle of the invention SVENSKA SOCKERFABRIKS AB (SE) 1987-04-14 — — US disclosed
EP-0035484-B1 COMPOSITION FOR THERAPEUTIC OR DIAGNOSTIC USE Källenius, Gunilla Petterson (SE) 1984-08-22 — — EP disclosed
EP-0035484-A2 Composition for therapeutic or diagnostic use Källenius, Gunilla Petterson (SE) 1981-09-09 — — EP disclosed
Send feedback